Effa EE, Bukirwa H, Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever) (Review). Cochrane Database of Systematic Reviews 2008, Issue 4, Art No: CD006083. DOI: 10.1002/14651858 CD006083.pub 2
Sinha A, Saizawal AK, Kumar R, Sood S, Reddaiah VP, Singh B, et al. Typhoid fever in children less than 5 years. Lancet 1999; 354: 734-737.
Ochiai RL, Acosta CJ, Danovara - Holliday MC, Baiqing D, Bhattacharya SK, Agtini MD, et al. Domi typhoid study group. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 2008; 86: 260-268.
Srivatsava SP, Singh UK, Jaiswal BP. Emergence of multi-drug resistant (MDR) enteric fever: an alarming threat to health of Indian children. 5th National CME of IAP Chapter on Pediatric Infectious Diseases, 23-24 June, 2007, Patna.
Bhutta ZA. Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child 1996; 75: 214-217.
Rowe B, Ward LR, Threlfall EJ. Multi-drug resistant Salmonella typhi: A world wide epidemic. Clinical Infectious Diseases 1997; 24: S106-109.
Bhutta ZA. The Challenge of Multi-drug Resistant Typhoid in Childhood: Current Status and Prospects for the future. Indian Pediatr 1999; 36: 129- 131.
Mirza SH, Bleeching NG, Hart CA. Multi-drug resistant typhoid: a global problem. Journal of Med Microbiol 1996; 44: 317-319.
Oh HML, Chew SK, Monteiro EH. Multi-drug resistant typhoid fever in Singapore. Singapore Med J 1994; 35: 599-601.
Mandal BK. Modern treatment of typhoid fever. J Infect 1991; 22: 1-4.
Rowe B, Threlfall EJ, Ward LR. Ciprofloxacin resistant Salmonella typhi in the UK. Lancet 1995; 346: 1302
Madhulika U, Harish BN, Parija SC. Current pattern in antimicrobial susceptibility of Salmonella typhi isolates in Pondicherry. Indian Journal Of Medical Research 2004; 120(2): 111-114.
Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J of Med Microbiol 2006; 24(1): 45-48.
Cohen ML, Tauxe RV. Drug resistant Salmonella typhi in the United States: an epidemiologic perspective. Science 1986; 234: 964-969. 15.Amdekar YK. Multi-drug resistant typhoid fever in children. Indian J of Med Ethics 2000; 8(2).
Wain I, Diep TS, Ho VA, Walsh AM, Hoa NT, Parry CM et al. Quantification of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility and antibiotic resistance. Clin Microbiol 1998; 36: 1683-1687.
IAP Task Force Report on Guidelines and Management of Enteric fever in children. Bulletin Infectious Diseases Chapter of IAP 2007; 7: 4-22.
Renuka K, Sood S, Das BK, Kapil A. High level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. J of Med Mircobiol 2005; 54: 999-1000.
Mushtaq MA. What after ciprofloxacin and ceftriaxone in the treatment of Salmonella typhi? Pakistan J of Med Sciences 2006; 22(1): 51-54.
Gupta A, Swankar NK, Choudhary SP. Changing antibiotic sensitivity in enteric fever. J Trop Ped 2001; 47: 369-371.
Mandal S, Mandal MD, Kumar NP. Reduced minimum inhibitory concentration of chloramphenicol for Salmonella enterica serovar Typhi. Indian J Med Sci 2004; 58: 16-28.
Girgis NI, Tribble DR, Sultan Y, Farid Z. Short course chemotherapy with cefixime in children with multi-drug resistant Salmonella typhi septicemia. J Trop Ped 1995; 41: 364-365.
Girgis NI, Butler T, Frenck RW, Sultan Y, Brown FM, Tribble D, et al. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with MDR. Antimicrobial Agents and Chemotherapy 1999; 43(6): 1441-1444.
